{"id":"https://openalex.org/W1995593304","doi":"https://doi.org/10.1007/s11912-003-0118-3","title":"Neoadjuvant therapy for high-risk localized prostate cancer","display_name":"Neoadjuvant therapy for high-risk localized prostate cancer","publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W1995593304","doi":"https://doi.org/10.1007/s11912-003-0118-3","mag":"1995593304","pmid":"https://pubmed.ncbi.nlm.nih.gov/12667424"},"language":"en","primary_location":{"id":"doi:10.1007/s11912-003-0118-3","doi":"https://doi.org/10.1007/s11912-003-0118-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11912-003-0118-3","pdf_url":null,"source":{"id":"https://openalex.org/S83206718","display_name":"Current Oncology Reports","issn_l":"1523-3790","issn":["1523-3790","1534-6269"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology Reports","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084909001","display_name":"Evan Y. Yu","orcid":"https://orcid.org/0000-0002-1510-8044","observed_orcids":["https://orcid.org/0000-0002-1510-8044"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Y. Yu","raw_affiliation_strings":["Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Dana 1230, 44 Binney Street, Boston, MA 02115, USA. evan_yu@cfci.harvard.edu","Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Dana 1230, 44 Binney Street, Boston, MA 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Dana 1230, 44 Binney Street, Boston, MA 02115, USA. evan_yu@cfci.harvard.edu","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Dana 1230, 44 Binney Street, Boston, MA 02115, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078027978","display_name":"William K. Oh","orcid":"https://orcid.org/0000-0001-5113-8147","observed_orcids":["https://orcid.org/0000-0001-5113-8147"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William K. Oh","raw_affiliation_strings":["Lank Center for Genitourinary Oncology, Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Dana 1230, 44 Binney Street, 02115, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lank Center for Genitourinary Oncology, Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Dana 1230, 44 Binney Street, 02115, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":null,"fwci":0.0811,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.09146341,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"3","first_page":"250","last_page":"257"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.3034999966621399,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/high-risk-localized-prostate-cancer","display_name":"high-risk localized prostate cancer","score":0.906000018119812},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.5410000085830688},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.6620000004768372},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/molecularly-targeted-agents","display_name":"molecularly targeted agents","score":0.828000009059906},{"id":"https://openalex.org/keywords/gleason-score","display_name":"Gleason score","score":0.9330000281333923},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.8809999823570251},{"id":"https://openalex.org/keywords/risk-of-recurrence","display_name":"recurrence risk","score":0.5019999742507935},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9584102630615234},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7485392093658447},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.6819473505020142},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6798997521400452},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5679380297660828},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5495166778564453},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.544675350189209},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5273826122283936},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.5029506087303162},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.45761245489120483},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4414077401161194},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40611836314201355},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.11710405349731445}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11912-003-0118-3","doi":"https://doi.org/10.1007/s11912-003-0118-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11912-003-0118-3","pdf_url":null,"source":{"id":"https://openalex.org/S83206718","display_name":"Current Oncology Reports","issn_l":"1523-3790","issn":["1523-3790","1534-6269"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology Reports","raw_type":"journal-article"},{"id":"pmid:12667424","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12667424","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current oncology reports","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W153934429","https://openalex.org/W1914356562","https://openalex.org/W1954763554","https://openalex.org/W1970825544","https://openalex.org/W1977140042","https://openalex.org/W1978267162","https://openalex.org/W1983444952","https://openalex.org/W1996330511","https://openalex.org/W2000272012","https://openalex.org/W2001553154","https://openalex.org/W2009248033","https://openalex.org/W2015621577","https://openalex.org/W2016055442","https://openalex.org/W2019378587","https://openalex.org/W2026151657","https://openalex.org/W2031663842","https://openalex.org/W2037610329","https://openalex.org/W2045679498","https://openalex.org/W2047043504","https://openalex.org/W2047302001","https://openalex.org/W2067475417","https://openalex.org/W2073412226","https://openalex.org/W2080136411","https://openalex.org/W2094616039","https://openalex.org/W2097120102","https://openalex.org/W2104115939","https://openalex.org/W2112294932","https://openalex.org/W2117792530","https://openalex.org/W2118157857","https://openalex.org/W2118495034","https://openalex.org/W2119114732","https://openalex.org/W2130215479","https://openalex.org/W2135203272","https://openalex.org/W2137568278","https://openalex.org/W2139962425","https://openalex.org/W2151175535","https://openalex.org/W2156569873","https://openalex.org/W2162559503","https://openalex.org/W2163014310","https://openalex.org/W2163120057","https://openalex.org/W2163818055","https://openalex.org/W2163895012","https://openalex.org/W2209020482","https://openalex.org/W2242179439","https://openalex.org/W2256486813","https://openalex.org/W2284485729","https://openalex.org/W2314503228","https://openalex.org/W2414021728","https://openalex.org/W2468934909","https://openalex.org/W2886935642","https://openalex.org/W4252605154","https://openalex.org/W4321059479"],"related_works":["https://openalex.org/W1990080469","https://openalex.org/W1976626835","https://openalex.org/W2808348563","https://openalex.org/W2032385479","https://openalex.org/W7213531669","https://openalex.org/W2402372578","https://openalex.org/W4234886037","https://openalex.org/W3030368587","https://openalex.org/W4406018447","https://openalex.org/W2086302071"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}